+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Systematic review and meta-analysis of a urine-based pneumococcal antigen test for diagnosis of community-acquired pneumonia caused by Streptococcus pneumoniae



Systematic review and meta-analysis of a urine-based pneumococcal antigen test for diagnosis of community-acquired pneumonia caused by Streptococcus pneumoniae



Journal of Clinical Microbiology 51(7): 2303-2310



Standard culture methods for diagnosis of Streptococcus pneumoniae pneumonia take at least 24 h. The BinaxNOW urine-based test for S. pneumoniae (BinaxNOW-SP) takes only 15 min to conduct, potentially enabling earlier diagnosis and targeted treatment. This study was conducted to assess whether the use of BinaxNOW-SP at the time of hospital admission would provide adequate sensitivity and specificity for diagnosis of community-acquired pneumonia (CAP) in adult patients. We searched PubMed, EMBASE/OVID, Cochrane Collaboration, Centre for Reviews and Dissemination, INAHTA, and CADTH for diagnostic or etiologic studies of hospitalized predominately adult patients with clinically defined CAP that reported the diagnostic performance of BinaxNOW-SP versus cultures. Two authors independently extracted study details and diagnostic two-by-two tables. We found that 27 studies met our inclusion criteria, and three different reference standards were used between them. A bivariate meta-analysis of 12 studies using a composite of culture tests as the reference standard estimated the sensitivity of BinaxNOW-SP as 68.5% (95% credibility interval [CrI], 62.6% to 74.2%) and specificity as 84.2% (95% CrI, 77.5% to 89.3%). A meta-analysis of all 27 studies, adjusting for the imperfect and variable nature of the reference standard, gave a higher sensitivity of 74.0% (CrI, 66.6% to 82·3%) and specificity of 97.2% (CrI, 92.7% to 99.8%). The analysis showed substantial heterogeneity across studies, which did not decrease with adjustment for covariates. We concluded that the higher pooled sensitivity (compared to culture) and high specificity of BinaxNOW-SP suggest it would be a useful addition to the diagnostic workup for community-acquired pneumonia. More research is needed regarding the impact of BinaxNOW-SP on clinical practice.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 036942868

Download citation: RISBibTeXText

PMID: 23678060

DOI: 10.1128/jcm.00137-13


Related references

Diagnosis of Streptococcus pneumoniae infections in adults with bacteremia and community-acquired pneumonia: clinical comparison of pneumococcal PCR and urinary antigen detection. Journal of Clinical Microbiology 47(4): 1046-1049, 2009

Evaluation of a rapid immunochromatographic test for the detection of Streptococcus pneumoniae antigen in urine samples from adults with community-acquired pneumonia. Abstracts of the General Meeting of the American Society for Microbiology 101: 174, 2001

Evaluation of a rapid immunochromatographic test for detection of Streptococcus pneumoniae antigen in urine samples from adults with community-acquired pneumonia. Journal of Clinical Microbiology 39(10): 3495-3498, 2001

Evaluation of the BinaxNOW® Streptococcus pneumoniae antigen test on fresh, frozen and concentrated urine samples in elderly patients with and without community-acquired pneumonia. Journal of Microbiological Methods 121: 24-26, 2016

Sensitivity and specificity of the Streptococcus pneumoniae urinary antigen test for unconcentrated urine from adult patients with pneumonia: a meta-analysis. Respirology 18(8): 1177-1183, 2013

The Binax NOW Streptococcus pneumoniae test applied on nasopharyngeal aspirates to support pneumococcal aetiology in community-acquired pneumonia. Scandinavian Journal of Infectious Diseases 45(6): 425-431, 2013

Urine antigen test to improve detection rate of Streptococcus pneumonia in community acquired pneumonia. Zhonghua Jie he He Hu Xi Za Zhi 38(1): 66-69, 2015

The effectiveness of the polysaccharide pneumococcal vaccine for the prevention of hospitalizations due to Streptococcus pneumoniae community-acquired pneumonia in the elderly differs between the sexes: results from the Community-Acquired Pneumonia Organization (CAPO) international cohort study. Vaccine 32(19): 2198-2203, 2014

Rapid urine antigen testing for Streptococcus pneumoniae in adults with community-acquired pneumonia: clinical use and barriers. Diagnostic Microbiology and Infectious Disease 79(4): 454-457, 2014

Rapid diagnosis of pneumococcal pneumonia in adults using the Binax NOW Streptococcus pneumoniae urinary antigen test. International Journal of Infectious Diseases 11(3): 284-285, 2007

Usefulness of the Streptococcus pneumoniae urinary antigen test in the treatment of community-acquired pneumonia. Clinical Infectious Diseases 41(8): 1209-1210, 2005

Use of serology and urine antigen detection to estimate the proportion of adult community-acquired pneumonia attributable to Streptococcus pneumoniae. Epidemiology and Infection 138(12): 1796-1803, 2010

Efficacy of 23-valent pneumococcal polysaccharide vaccine in preventing community-acquired pneumonia among immunocompetent adults: A systematic review and meta-analysis of randomized trials. Vaccine 34(13): 1496-1503, 2016

The efficacy of high-dose penicillin for community-acquired pneumonia diagnosed by pneumococcal urine antigen test. Journal of Infection and ChemoTherapy 15(2): 108-112, 2009

The Characteristics and Usefulness of Streptococcus Pneumoniae Urinary Antigen Test in Evaluating patients with Community-Acquired Pneumonia. Chest Journal 126(4): 858sc-1-858sc-2, 2004